Recent change in spectrum of HIV-linked kidney disease

December 14, 2017

(HealthDay)—The spectrum of HIV-associated kidney disease has changed with the improvement of therapy for HIV infection, according to a review article published in the Dec. 14 issue of the New England Journal of Medicine.

Scott D. Cohen, M.D., M.P.H., from George Washington University in Washington, D.C., and colleagues discussed the spectrum of HIV-associated renal diseases, including diseases that are directly linked with infection and those that are linked to HIV treatment.

The researchers note that over the last three decades, has transformed HIV to a chronic illness, with associated changes in the incidence, type, and severity of kidney diseases. There has been an increase in evidence of nephrotoxic effects of antiretroviral therapy and the prevalence of kidney diseases resulting from aberrant metabolism and aging. HIV-associated nephropathy has decreased in frequency and is now known to arise from interactions among the virus, host genotype, host response, and effective treatment. The subgroup of HIV-infected patients with immune-complex renal disease is increasingly being recognized, and the prevalence of this type of disease may be increasing as a result of successful HIV therapy. For patients with HIV in whom end-stage renal disease develops, kidney transplantation holds promise to increase the quantity and quality of life.

"Additional research, including well-designed randomized, controlled trials, is needed to determine effective therapeutic approaches to treating the diverse renal manifestations of HIV infection and improve the outcomes of treatment," the authors write.

Explore further: HCV treatment found safe and effective in individuals with kidney disease

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

HCV treatment found safe and effective in individuals with kidney disease

September 7, 2017
A new study indicates that direct-acting antiviral therapy is safe and effective in patients with chronic kidney disease (CKD) and Hepatitis C virus (HCV) infection. The study, which appears in an upcoming issue of the Clinical ...

High sustained response rate for glecaprevir, pibrentasvir in HCV

October 12, 2017
(HealthDay)—For patients with stage 4 or 5 chronic kidney disease and hepatitis C virus (HCV) infection, 12 weeks of treatment with glecaprevir and pibrentasvir results in a high rate of sustained virologic response, according ...

Liraglutide tied to reduced progression of diabetic kidney disease

September 4, 2017
(HealthDay)—For patients with type 2 diabetes and high cardiovascular risk receiving usual care, the addition of liraglutide is associated with lower rates of development and progression of diabetic kidney disease, according ...

Will blocking IL-17A help treat kidney disease?

January 22, 2016
Many different diseases and insults can injure kidneys, resulting in kidney failure. Some autoimmune diseases damage glomeruli (the 'filtering units' of the kidney), while problems with the tubules (for example, impaired ...

New tools to combat kidney fibrosis

October 16, 2017
Interstitial fibrosis – excessive tissue scarring – contributes to chronic kidney disease, which is increasing in prevalence in the United States.

Nonalbuminuric CKD ups cardiovascular morbidity in T1DM

August 31, 2015
(HealthDay)—Nonalbuminuric chronic kidney disease is associated with increased risk of cardiovascular disease and all-cause mortality, but not renal outcomes, in patients with type 1 diabetes, according to a study published ...

Recommended for you

Drugs that stop mosquitoes catching malaria could help eradicate the disease

September 18, 2018
Researchers have identified compounds that could prevent malaria parasites from being able to infect mosquitoes, halting the spread of disease.

Vaccine opt-outs dropped slightly when California added more hurdles

September 18, 2018
In response to spiking rates of parents opting their children out of vaccinations that are required to enroll in school—and just before a huge outbreak of measles at Disneyland in 2014—California passed AB-2109. The law ...

New evidence of a preventative therapy for gout

September 17, 2018
Among patients with cardiovascular disease, it's a common complaint: a sudden, piercing pain, stiffness or tenderness in a joint that lasts for days at a time with all signs pointing to a gout attack. Gout and cardiovascular ...

"Atypical" virus discovered to be driver of certain kidney diseases

September 14, 2018
An international research team led by Wolfgang Weninger has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy). This "atypical" virus, which the scientists ...

Flu shot rates in clinics drop as day progresses, but nudges help give them a boost

September 14, 2018
Primary care clinics experienced a significant decline in influenza vaccinations as the day progressed, researchers from Penn Medicine report in a new study published in JAMA Open Network. However, "nudging" clinical staff ...

Cancer drug and antidepressants provide clues for treating brain-eating amoeba infections

September 13, 2018
The amoeba Naegleria fowleri is commonly found in warm swimming pools, lakes and rivers. On rare occasions, the amoeba can infect a healthy person and cause severe primary amebic meningoencephalitis, a "brain-eating" disease ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.